Nodelman Oleg
- SEC CIK
- 0001454385
In the past year, 1 open-market purchase filing worth $40.0M and no sales.
Current role at each company
- AKTS Aktis Oncology, Inc.Directoras of Jan 12, 2026
- ZYME Zymeworks Inc.Director, 10% Owneras of Jun 27, 2025
- ANAB Anaptysbio, IncDirector, 10% Owneras of Jan 2, 2025
- NUVB Nuvation Bio Inc.Directoras of Sep 22, 2023
- Panacea Acquisition Corp. IIDirector, 10% Owneras of May 2, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- $40.0M
- 1 filing
- Sold
- –
- 0 filings
- Net
- +$40.0M
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Nodelman Oleg as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
AKTS Aktis Oncology, Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jan 12, 2026 (view filing)8:28 PM ET | Jan 12 | Same day | Nodelman Oleg and 1 otherDirector | PPurchase | +2.22M | $18.00 | +$40.0M | New position347.3K after | 2 lots |
ZYME Zymeworks Inc.
Director, 10% Owner8 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 19, 2025 (view filing)6:35 PM ET | May 15-19 | 4 days | Nodelman Oleg and 1 otherDirector, 10% Owner | PPurchase | +55.4K | $11.47 | +$635.6K | +0.3%17.9M after | 2 lots |
| Apr 18, 2025 (view filing)3:17 PM ET | Apr 16-17 | 2 days | Nodelman Oleg and 1 otherDirector, 10% Owner | PPurchase | +128.7K | $11.32 | +$1.46M | +0.7%17.8M after | 2 lots |
| Apr 7, 2025 (view filing)6:34 PM ET | Apr 3-4 | 4 days | Nodelman Oleg and 1 otherDirector, 10% Owner | PPurchase | +317.2K | $11.42 | +$3.62M | +1.8%17.7M after | 2 lots |
| Apr 2, 2025 (view filing)7:02 PM ET | Mar 31-Apr 2 | 2 days | Nodelman Oleg and 1 otherDirector, 10% Owner | PPurchase | +127.4K | $11.75 | +$1.50M | +0.7%17.4M after | 3 lots |
| Mar 27, 2025 (view filing)6:53 PM ET | Mar 25-26 | 2 days | Nodelman Oleg and 1 otherDirector, 10% Owner | PPurchase | +97.3K | $12.61 | +$1.23M | +0.6%17.3M after | 2 lots |
| Mar 24, 2025 (view filing)5:45 PM ET | Mar 20-24 | 4 days | Nodelman Oleg and 1 otherDirector, 10% Owner | PPurchase | +127.2K | $12.92 | +$1.64M | +0.7%17.2M after | 3 lots |
| Mar 19, 2025 (view filing)6:32 PM ET | Mar 17-19 | 2 days | Nodelman Oleg and 1 otherDirector, 10% Owner | PPurchase | +228.5K | $12.55 | +$2.87M | +1.4%17.0M after | 3 lots |
| Mar 13, 2025 (view filing)7:35 PM ET | Mar 11-13 | 2 days | Nodelman Oleg and 1 otherDirector, 10% Owner | PPurchase | +1.08M | $12.13 | +$13.1M | +6.9%16.8M after | 3 lots |
ANAB Anaptysbio, Inc
Director, 10% Owner3 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jan 2, 2025 (view filing)6:17 PM ET | Dec 30, 2024-Jan 2, 2025 | 3 days | Nodelman Oleg and 1 otherDirector, 10% Owner | PPurchase | +85.1K | $12.92 | +$1.10M | +1.1%7.88M after | 3 lots |
| May 9, 2022 (view filing)6:04 AM ET | May 5 | 4 days | Nodelman Oleg and 1 otherDirector, 10% Owner | PPurchase | +668.2K | $21.63 | +$14.5M | +9.8%7.52M after | |
| May 9, 2022 (view filing)6:04 AM ET | May 5 | 4 days | Nodelman Oleg and 1 otherDirector, 10% Owner | SSale | −668.2K | $21.63 | −$14.5M | −8.2%7.52M after |
NUVB Nuvation Bio Inc.
Director4 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 22, 2023 (view filing)3:44 PM ET | Sep 19-21 | 3 days | Nodelman Oleg and 5 othersDirector | PPurchaseClass A Common Stock | +5.31M | $1.26 | +$6.69M | +72.2%12.7M after | Amended3 lots |
| Nov 30, 2021 (view filing)6:07 PM ET | Mar 31-Nov 24 | 244 daysLate | Nodelman Oleg and 5 othersDirector | PPurchaseClass A Common Stock | +393.2K | $8.89 | +$3.49M | +50.7%1.17M after | 4 lots |
| Nov 30, 2021 (view filing)6:07 PM ET | Mar 31 | 244 daysLate | Nodelman Oleg and 5 othersDirector | SSaleClass A Common Stock | +151.5K | $10.45 | +$1.58M | +15.2%1.15M after | |
| Nov 30, 2021 (view filing)6:07 PM ET | Jul 31 | 122 daysLate | Nodelman Oleg and 5 othersDirector | SSaleClass A Common Stock | −56.6K | $8.64 | −$489.0K | −4.7%1.15M after |